ROCKET PHARMACEUTICALS, INC. Annual Operating Lease, Payments in USD from 2019 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.
Summary
Rocket Pharmaceuticals, Inc. quarterly/annual Operating Lease, Payments history and growth rate from 2019 to 2023.
  • Rocket Pharmaceuticals, Inc. Operating Lease, Payments for the quarter ending March 31, 2024 was $333K, a 27.6% increase year-over-year.
  • Rocket Pharmaceuticals, Inc. annual Operating Lease, Payments for 2023 was $1.23M, a 31% increase from 2022.
  • Rocket Pharmaceuticals, Inc. annual Operating Lease, Payments for 2022 was $938K, a 43.2% increase from 2021.
  • Rocket Pharmaceuticals, Inc. annual Operating Lease, Payments for 2021 was $655K, a 27.1% decline from 2020.
Operating Lease, Payments, Annual (USD)
Operating Lease, Payments, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $1.23M +$291K +31% Jan 1, 2023 Dec 31, 2023 10-K 2024-02-27
2022 $938K +$283K +43.2% Jan 1, 2022 Dec 31, 2022 10-K 2024-02-27
2021 $655K -$243K -27.1% Jan 1, 2021 Dec 31, 2021 10-K 2024-02-27
2020 $898K -$190K -17.5% Jan 1, 2020 Dec 31, 2020 10-K 2021-03-01
2019 $1.09M Jan 1, 2019 Dec 31, 2019 10-K 2020-03-06
* An asterisk sign (*) next to the value indicates that the value is likely invalid.